These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 856557)

  • 41. Combination therapy with digoxin and diltiazem controls ventricular rate in chronic atrial fibrillation in dogs better than digoxin or diltiazem monotherapy: a randomized crossover study in 18 dogs.
    Gelzer AR; Kraus MS; Rishniw M; Moïse NS; Pariaut R; Jesty SA; Hemsley SA
    J Vet Intern Med; 2009; 23(3):499-508. PubMed ID: 19645836
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sotalol vs metoprolol for ventricular rate control in patients with chronic atrial fibrillation who have undergone digitalization: a single-blinded crossover study.
    Kochiadakis GE; Kanoupakis EM; Kalebubas MD; Igoumenidis NE; Vardakis KE; Mavrakis HE; Vardas PE
    Europace; 2001 Jan; 3(1):73-9. PubMed ID: 11271956
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
    Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effectiveness and safety of oral verapamil to control exercise-induced tachycardia in patients with atrial fibrillation receiving digitalis.
    Panidis IP; Morganroth J; Baessler C
    Am J Cardiol; 1983 Dec; 52(10):1197-201. PubMed ID: 6359848
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diltiazem and exercise performance in patients with chronic atrial fibrillation.
    Atwood JE; Myers JN; Sullivan MJ; Forbes SM; Pewen WF; Froelicher VF
    Chest; 1988 Jan; 93(1):20-5. PubMed ID: 3335153
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin.
    Rawles JM; Metcalfe MJ; Jennings K
    Br Heart J; 1990 Apr; 63(4):225-7. PubMed ID: 2337493
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Consumer wearable devices for evaluation of heart rate control using digoxin versus beta-blockers: the RATE-AF randomized trial.
    Gill SK; Barsky A; Guan X; Bunting KV; Karwath A; Tica O; Stanbury M; Haynes S; Folarin A; Dobson R; Kurps J; Asselbergs FW; Grobbee DE; Camm AJ; Eijkemans MJC; Gkoutos GV; Kotecha D; ; ;
    Nat Med; 2024 Jul; 30(7):2030-2036. PubMed ID: 39009776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. When, and when not, to use digoxin in the elderly.
    Gosselink AT; van Veldhuisen DJ; Crijns HJ
    Drugs Aging; 1997 Jun; 10(6):411-20. PubMed ID: 9205847
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravenously administered digoxin in patients with acute atrial fibrillation: a population pharmacokinetic/pharmacodynamic analysis based on the Digitalis in Acute Atrial Fibrillation trial.
    Hornestam B; Jerling M; Karlsson MO; Held P;
    Eur J Clin Pharmacol; 2003 Mar; 58(11):747-55. PubMed ID: 12634981
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rate-control treatment and mortality in atrial fibrillation.
    Chao TF; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA
    Circulation; 2015 Oct; 132(17):1604-12. PubMed ID: 26384160
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rate control in atrial fibrillation: choice of treatment and assessment of efficacy.
    Boriani G; Biffi M; Diemberger I; Martignani C; Branzi A
    Drugs; 2003; 63(14):1489-509. PubMed ID: 12834366
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rate control in atrial fibrillation.
    Van Gelder IC; Rienstra M; Crijns HJ; Olshansky B
    Lancet; 2016 Aug; 388(10046):818-28. PubMed ID: 27560277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and safety of oral amiodarone in controlling heart rate in patients with persistent atrial fibrillation who have undergone digitalisation.
    Kochiadakis GE; Kanoupakis EM; Igoumenidis NE; Mavrakis HE; Kafarakis PK; Vardas PE
    Hellenic J Cardiol; 2005; 46(5):336-40. PubMed ID: 16295942
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lidocaine-induced cardiac rate changes in atrial fibrillation and atrial flutter.
    Danahy DT; Aronow WS
    Am Heart J; 1978 Apr; 95(4):474-82. PubMed ID: 636985
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heart rate control in patients with chronic atrial fibrillation and heart failure.
    Silvet H; Hawkins LA; Jacobson AK
    Congest Heart Fail; 2013; 19(1):25-8. PubMed ID: 22958623
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Comparative study on the bradycardizing effect of beta-methyl-digoxin and digoxin in chronic auricular fibrillation].
    Pallares C; Richart JA; Bros R; Luque MT; Saenz L; Gausi C
    Rev Esp Cardiol; 1979; 32(1):21-9. PubMed ID: 441482
    [No Abstract]   [Full Text] [Related]  

  • 57. Left ventricular performance during acute rate control in atrial fibrillation: the importance of heart rate and agent used.
    Pinter A; Dorian P; Paquette M; Ng A; Burns M; Spanu I; Freeman M; Korley V; Newman D
    J Cardiovasc Pharmacol Ther; 2003 Mar; 8(1):17-24. PubMed ID: 12652326
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacological rate control of atrial fibrillation.
    Tamariz LJ; Bass EB
    Cardiol Clin; 2004 Feb; 22(1):35-45. PubMed ID: 14994846
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical decision analysis modeling: short-term control of ventricular response rate in atrial fibrillation or atrial flutter-digoxin versus diltiazem.
    Gonzalez ER; Ornato JP; Lawson CL
    Pharmacotherapy; 1994; 14(4):446-51. PubMed ID: 7937281
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is there a role for digoxin in atrial fibrillation without heart failure?
    Master J; Schweitzer P
    Cardiol J; 2009; 16(5):483-6. PubMed ID: 19753533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.